Drug Shortage Report for INDERAL-LA

Last updated on 2022-02-25 History
Report ID 155568
Drug Identification Number 02042266
Brand name INDERAL-LA
Common or Proper name INDERAL-LA
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PROPRANOLOL HYDROCHLORIDE
Strength(s) 120MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100's
ATC code C07AA
ATC description BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-02-24
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-02-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-02-25 English Compare
v2 2022-02-24 French Compare
v1 2022-02-24 English Compare

Showing 1 to 3 of 3